MNPR   $20.2  2.49% Market Closed After Close 19.6512 -2.72%

Monopar Therapeutics Inc
Total Cash 7.12M
totalCashPerShare 2.022
EBITDA
Total Debt 0.00
quickRatio 6.534
currentRatio 6.59
Total Revenue
debtToEquity
Revenue/Share
ROA -0.53445
ROE -1.02307
grossProfits
freeCashflow -4.43M
operatingCashflow -6.82M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 48.33M
forwardPE -6.362903
floatShares 1.62M
sharesOutstanding 5.28M
sharesShort 49.85K
sharesShortPriorMonth 652.49K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.43%
heldPercentInstitutions 0.15%
Short Ratio help_outline 0.15%
shortPercentOfFloat 0.10%
impliedSharesOutstanding
bookValue 1.73
Price To Book help_outline 9.12
earningsQuarterlyGrowth
netIncomeToCommon -7.12M
trailingEps -2.30%
forwardEps -2.48%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.48 3Q 2024
institutionsCount 12
lastUpdated Nov. 7, 2024, 3:04 a.m.